Disease: Graft-vs-Host Disease ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0018133
Disease: Graft-vs-Host Disease
Graft-vs-Host Disease 		0.030 Biomarker disease BEFREE However, the infusion of allogeneic CAR-T cells may also cause graft-versus-host disease, which limited their applications during and after allo-HSCT. 30702011 2019
CUI: C0018133
Disease: Graft-vs-Host Disease
Graft-vs-Host Disease 		0.030 Biomarker disease BEFREE Here, transcription activator-like effector nuclease (TALEN) gene editing of B cell maturation antigen (BCMA) CAR Ts was used to confer lymphodepletion resistance and reduced graft-versus-host disease (GvHD) potential. 31005597 2019
CUI: C0018133
Disease: Graft-vs-Host Disease
Graft-vs-Host Disease 		0.030 Biomarker disease BEFREE Use of donor-derived CAR T cell for relapse prophylaxis, minimal residual disease clearance or salvage from relapse is therefore highly effective, and risk of graft versus host disease flare is very low. 28128714 2017